Who invested in Cardinal Analytx?
Cardinal Analytx's investors include John Doerr, Stanford-StartX, Premera Blue Cross, Blue Shield California and Cardinal Partners/ Premera Blue Cross, and 1 more on record. John Doerr led its latest round.
United States · Series B startup
2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$28Mraised across 2 rounds since 2017, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEsSEC filing: $21M sold, first sale Mar 2019
Reported by FinSMEsSEC filing: $2.8M sold, first sale May 2017
From the SEC filings it signed: 2 on the team.
On the board, as filediElizabeth T. SpauldingKent T. MarquardtMark T. SmithThomas T. McKinley
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Cardinal Analytx's investors include John Doerr, Stanford-StartX, Premera Blue Cross, Blue Shield California and Cardinal Partners/ Premera Blue Cross, and 1 more on record. John Doerr led its latest round.
Cardinal Analytx has raised $28M across 2 rounds since 2017.
Cardinal Analytx's most recent round was a Series B of $22M in May 2019, led by John Doerr.
Its most recent round, $22M in May 2019, is also its largest on record.
Cardinal Analytx's first round on record, in Sept 2017, was backed by Stanford-StartX and Cardinal Partners/ Premera Blue Cross.
Cardinal Analytx's latest named round is a Series B, in May 2019.
Cardinal Analytx is based in the United States.
John Doerr led the Series B in 2019.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.